atrasentan has been researched along with taxane in 1 studies
Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (taxane) | Trials (taxane) | Recent Studies (post-2010) (taxane) |
---|---|---|---|---|---|
358 | 41 | 108 | 1,288 | 210 | 779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhavan, A; Bies, RR; Guruli, G; McHugh, KH; Nelson, JB; Pflug, BR; Strychor, SA; Zamboni, WC | 1 |
1 other study(ies) available for atrasentan and taxane
Article | Year |
---|---|
Endothelin receptor A blockade enhances taxane effects in prostate cancer.
Topics: Animals; Apoptosis; Atrasentan; Bridged-Ring Compounds; Cell Survival; Endothelin A Receptor Antagonists; Humans; Ki-67 Antigen; Male; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Prostatic Neoplasms; Pyrrolidines; Taxoids | 2006 |